Tiotropium as add-on therapy to inhaled corticosteroids for patients with symptomatic asthma: Lung function and safety

被引：0

作者：

Kerstjens, H. A. M. ^{[1
]}

Bleecker, E. ^{[2
]}

Meltzer, E. ^{[3
]}

Casale, T. ^{[4
]}

Pizzichini, E. ^{[5
]}

Schmidt, O. ^{[6
]}

Engel, M. ^{[7
]}

Bour, L. J. ^{[8
]}

Verkleij, C. B. ^{[9
]}

Moroni-Zentgraf, P. M. ^{[7
]}

Bateman, E. D. ^{[10
]}

机构：

[1] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Med, Groningen, Netherlands

[2] Wake Forest Sch Med, Ctr Genom & Personalized Med, Winston Salem, NC USA

[3] Allergy & Asthma Med Grp & Res Ctr, San Diego, CA USA

[4] Creighton Univ, Div Allergy & Immunol, Omaha, NE 68178 USA

[5] Univ Fed Santa Catarina, NUPAIVA, Asthma Res Ctr, BR-88040900 Florianopolis, SC, Brazil

[6] KPPK GmbH, Koblenz, Germany

[7] Boehringer Ingelheim Pharma GmbH & Co KG, TA Resp Dis, Ingelheim, Germany

[8] Boehringer Ingelheim Pharma GmbH & Co KG, Biostat, Biberach, Germany

[9] Boehringer Ingelheim BV, Dept Med, Alkmaar, Netherlands

[10] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa

来源：

EUROPEAN RESPIRATORY JOURNAL | 2013年 / 42卷

关键词：

Asthma; -; management; Bronchodilators; Lung function testing;

D O I：

暂无

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

2085

引用

页数：2

共 50 条

[41] EFFICACY, SAFETY AND TOLERABILITY OF ONCE-DAILY TIOTROPIUM RESPIMAT® ADD-ON THERAPY IN CHILDREN WITH MODERATE SYMPTOMATIC ASTHMA
Schmidt, O.
Hamelmann, E.
Vogelberg, C.
Laki, I.
El Azzi, G.
Engel, M.
Moroni-Zentgraf, P.
Finnigan, H.
Vandewalker, M.
THORAX, 2016, 71 : A167 - A168
[42] EFFICACY, SAFETY AND TOLERABILITY OF ONCE-DAILY TIOTROPIUM RESPIMAT® ADD-ON THERAPY IN CHILDREN WITH MODERATE SYMPTOMATIC ASTHMA
不详
THORAX, 2016, 71 : A272 - A272
[43] Tiotropium Respimat® Add-On Therapy Improves Lung Function In Adolescents And Children With Moderate Symptomatic Asthma, Irrespective Of Ige Levels And Eosinophil Count
Vandewalker, M.
Vogelberg, C.
Hamelmann, E.
Goldstein, S.
Voelker, B.
El Azzi, G.
Sigmund, R.
Engel, M.
Bernstein, J. A.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
[44] Add-on therapy options in asthma not adequately controlled by inhaled corticosteroids: a comprehensive review
Hannu Kankaanranta
Aarne Lahdensuo
Eeva Moilanen
Peter J Barnes
Respiratory Research, 5
[45] Add-on therapy options in asthma not adequately controlled by inhaled corticosteroids: a comprehensive review
Kankaanranta, H
Lahdensuo, A
Moilanen, E
Barnes, PJ
RESPIRATORY RESEARCH, 2004, 5 (17):
[46] SAFETY PROFILE OF TIOTROPIUM ADD-ON THERAPY IN PAEDIATRIC PATIENTS BY GENDER
Vogelberg, C.
Engel, M.
Vulcu, S. D.
Hamelmann, E.
THORAX, 2018, 73 : A195 - A195
[47] Safety profile of tiotropium add-on therapy in paediatric patients by gender
Vogelberg, Christian
Hamelmann, Eckard
Engel, Michael
El Azzi, Georges
Vulcu, Sebastian Dan
Szefler, Stanley
EUROPEAN RESPIRATORY JOURNAL, 2018, 52
[48] Tiotropium Respimat® Add-On Therapy To Inhaled Corticosteroids (ics) plus Long-Acting β2-Agonists (labas) In Patients With Symptomatic Severe Asthma: Efficacy By Level Of Airway Obstruction
Kerstjens, H. A. M.
Engel, M.
Dahl, R.
Paggiaro, P.
Beck, E.
Vandewalker, M.
Sigmund, R.
Moroni-Zentgraf, P.
Bateman, E. D.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
[49] TIOTROPIUM RESPIMAT® ADD-ON THERAPY TO INHALED CORTICOSTEROIDS (ICS) plus LONG-ACTING β2-AGONISTS (LABAS) IN PATIENTS WITH SYMPTOMATIC SEVERE ASTHMA: EFFICACY BY LEVEL OF AIRWAY OBSTRUCTION
Frith, P.
Kerstjens, H.
Engel, M.
Dahl, R.
Paggiaro, P.
Beck, E.
Vandewalker, M.
Sigmund, R.
Moroni-Zentgraf, P.
Bateman, E.
RESPIROLOGY, 2016, 21 : 107 - 107
[50] 1-year efficacy and safety study of tiotropium respimat add-on to ICS in adolescent patients with symptomatic asthma
Hamelmann, Eckard
Boner, Attilio
Bernstein, Jonathan
Moroni-Zentgraf, Petra
Engel, Michael
Avis, Mandy
Unseld, Anna
Vandewalker, Mark
EUROPEAN RESPIRATORY JOURNAL, 2014, 44

← 1 2 3 4 5 →